HCA Healthcare Inc $ 153.05 -0.57 (-0.37%)
HCA News and Headlines - HCA Healthcare Inc
The guru's Boston-based hedge fund manages about $29 billion in assets as of June 30, 2019. It searches for value among a broad range of opportunities, including stocks, distressed debt, liquidations and foreign securities. With a long-term horizon, the renowned investor typically seeks securities trading well below his estimate of intrinsic value and waits for the price to rise. In March, Bloomberg reported that for the first time since 2011, Klarman was seeking more capital as
HCA Healthcare (HCA) (U.S.) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. Although the Covid-19 pandemic created disruptions across the hospital sector, HCA's fundamentals have held up remarkably well. Management believes the company will be in an even stronger position coming out of the crisis than it was coming into it and that demand for health care services will be robust for years to come.
We bought one new position in the Fund this quarter, HCA Healthcare (HCA). HCA has been a longstanding holding in more diversified Oakmark portfolios, including the Oakmark Fund and the Oakmark Equity and Income Fund. We were happy to take advantage of the pandemic-driven stock price volatility to add it to the Select Fund during the quarter. HCA is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital
According to the GuruFocus All-in-One Screener, a Premium feature, as of Sept. 8, the following guru-held companies have positive future earnings estimates from Morningstar analysts.
Shares of CVS Health Corp. (CVS) were trading around $60.20 on Tuesday.
The drug store chain owner has a GuruFocus profitability rating of 8 out of 10. Its earnings per share have increased 1.10% over the past three years.
Analysts project a three-year to five-year earnings growth rate of 7.92%. While the return on equity of 12.87% is outperforming the sector, return on assets of 3.66%
Greenberg and John Shapiro founded Chieftain Capital Management in 1984, and when the partners split the firm up into two separate companies in 2010, Greenberg's firm was renamed Brave Warrior Investors. Greenberg runs a highly concentrated portfolio, which he holds is a "defense against ignorance," as the more companies you own, the less you know about each. He prefers to invest in companies with little competition, high return on invested capital and good balance
Investors should note that while the report does give us an insight into the equity portfolio of this hedge fund, it does not provide the complete picture. The 13F filings do not detail credit holdings, real estate investments or private equity investments. We know Baupost has substantial investments in each of these asset classes. It also has a large cash allocation, which has averaged around 30% of assets under
Seth Klarman (Trades, Portfolio), manager of Baupost Group, disclosed this week that his top five trades included a new holding in HCA Healthcare Inc. (HCA) and sells in the following four companies: Cheniere Energy Inc. (LNG), Facebook Inc. (FB), Alphabet Inc. (GOOG) and Energy Transfer LP (ET).
A Harvard MBA graduate, Klarman wrote the book "Margin of Safety," which discusses risk-averse value investing strategies for the thoughtful investor. The manager of the Boston-based firm invests in a wide range of securities, including common stock, distressed debt, liquidations, foreign equities and bonds. Despite this, Klarman does not mind
The following companies have grown their earnings per share over a five-year period. According to the GuruFocus discounted cash flow calculator as of June 30, all of them also trade with a margin of safety.
Biogen Inc.'s (BIIB) earnings per share have grown 16.5% per annum over the past five years.
According to the DCF calculator, the stock is undervalued with a 71.77% margin of safety at $260 per share. The price-earnings ratio is 8.04. The share price has been as high as $374.99 and as low as $215.78 in the last 52
According to the GuruFocus All-in-One Screener, a Premium feature, the following companies have high business predictability ratings and wide margins of safety as of June 24.
Mobile TeleSystems PJSC (MBT) has a business predictability rank of 4.5 out of 5 stars and, according to the discounted cash flow calculator, a 10.96% margin of safety at an average price of $9.34 per share.
The Russian wireless operator has a market cap of $8.7 billion and an enterprise value of $13.8 billion. Over the past five years, its revenue has grown 2.5%.
In the first quarter of 2020, many gurus had unusually high turnover rates in their portfolios as the market downturn in March led them to re-evaluate their holdings and distribute their funds to new value opportunities.
According to GuruFocus’ Hot Picks, a Premium feature which allows investors to screen for the stocks that had the most guru buys or sells over a specific time frame, the most popular stocks among gurus during the first quarter (as determined by net buys) were Wells Fargo & Co. (WFC), Booking Holdings Inc. (BKNG), Charles Schwab Corp. (SCHW), Baidu Inc. (BIDU) and HCA
Glenview Capital Management, the firm founded by Larry Robbins (Trades, Portfolio), disclosed over the past few weeks that its top five sells during the first quarter were in Cigna Corp. (CI), HCA Healthcare Inc. (HCA), Hologic Inc. (HOLX), IQVIA Holdings Inc. (IQV) and The Walt Disney Co. (DIS). Cigna and HCA are among the firm’s top five holdings as of March 31.
The New York-based firm manages approximately $13.3 billion in assets as of the latest ADV form, split between the long-and-short Glenview Funds and a concentrated, optimistic Glenview Opportunity Funds. The firm seeks capital appreciation
Glenn Greenberg (Trades, Portfolio), manager of New York-based Brave Warrior Advisors, disclosed last week that his top four buys for the first quarter included new stakes in HCA Healthcare Inc. (HCA) and Facebook Inc. (FB) and position boosts in Primerica Inc. (PRI) and Anthem Inc. (ANTM).
Managing a portfolio of 22 stocks, Greenberg maintains a highly concentrated portfolio that he describes as “defense against ignorance.” Greenberg believes that the more companies one owns, the less one will know about each and can lead to investing mistakes due to fear and greed.
The largest for-profit acute care hospital system in the US by revenues, HCA (HCA) is a high- quality company, in our view. During the quarter, the company announced plans to issue new debt for the purpose of redeeming its 2021 paper. The short tenor of this particular bond issue also appeared to help buoy it in a difficult market, as longer HCA paper was much more volatile during the period.
From the First Eagle High Income Fund's first-quarter 2020 shareholder commentary.
The emergence of the novel coronavirus and the economic impact of efforts to contain its transmission led to a deep, sharp repricing of risk assets during the first quarter as liquidity concerns emerged across financial markets. The Bloomberg Barclays US Corporate High Yield Index fell nearly 13% during the period;1 though lower-quality issues suffered the most, the dispersion of perfor-mance among credit tiers wasn’t as significant as one might expect given the magnitude of the selloff. While the quarter as a whole was bad for high yield bonds, March was historically so, even if a late-month rally took
According to GuruFocus’ list of 52-week lows, these Guru stocks have reached their 52-week lows.
The price of HCA Healthcare Inc. (HCA) shares has declined to close to the 52-week low of $104.28, which is 33.5% off the 52-week high of $151.97. The company has a market cap of $35.29 billion.
Its shares traded with a price-earnings ratio of 10.36 and a price-sales ratio of 0.71 as of March 13. The trailing 12-month dividend yield is 1.56%. The forward dividend yield is 1.65%. The company had an annual average earnings growth of 8.70%
Companies that are growing their earnings are often good investments because they can return a solid profit to investors. According to the discounted cash flow calculator as of Tuesday, the following undervalued companies have grown their earnings per share over a five-year period.
HCA Healthcare Inc.'s (HCA) earnings per share have grown 22.90% per annum over the past five years.
According to the DCF calculator, the stock is undervalued with a 48% margin of safety at $116 per share. The price-earnings ratio is 11.33. The share price has been as high as $147.42
With the goal of delivering attractive absolute returns, the guru’s New York-based hedge fund focuses on deep fundamental research and individual security selection. It operates two funds: the Glenview Fund, a long-and-short strategy, and the Glenview Opportunity Fund, which is more concentrated. Most of its investments are in U.S. stocks, but it does have some exposure to Western Europe.
According to GuruFocus Real-Time Picks, a Premium feature, Robbins invested in 3.28 million shares of
Screening for stocks that more than double the earnings yield of 20-year high-quality corporate bonds increases the likelihood of finding value opportunities.
These bonds represent corporate loans issued by triple-A, double-A and single-A-rated companies and reward their holders with an average monthly spot rate of 3.82%, according to the Federal Reserve Bank of St. Louis.
As a result, the following companies have a price-earnings ratio, which is the inverse of the earnings yield, of less than 13.09.
Shares of Intel Corp. (INTC) closed at $50.72 on Friday for a market capitalization of $224.69 billion. The Santa Clara, California-based
According to GuruFocus, these stocks have recently reached their 52-week highs.
HCA Healthcare Inc. (HCA) reached the 52-week high of $145.06
Accounting for about 5% of total U.S. hospital admissions, HCA is the largest private hospital owner and operator in the U.S. It operates 170 hospitals and 118 outpatient centers, offering a broad range of health services.
The price of HCA Healthcare shares has reached $145.06, which is 1.6% off the 52-week high of $147.42. The company has a market cap of $49.66 billion; its shares were traded around $145.06 with a price-earnings ratio of
Health care stocks took a hit last week after President Donald Trump signed an executive order calling for more transparency in disclosing hospital costs to patients.
As a result, value opportunities may be found among companies in the health care industry that are trading below Peter Lynch value.
Lynch, a renowned investor who generated an average 29.2% annual return while running Fidelity’s Magellan Fund, developed this method in order to simplify his stock-picking process. With the belief that good, stable companies eventually trade at 15 times their annual earnings, he set the standard at a price-earnings ratio of 15. Stocks